FDA Issues Warning Over Avandia Amid Outcry
On Monday, the FDA tossed out a stiff caution regarding the GlaxoSmithKline medication, which is primarily used to treat type 2 diabetes.
“Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia,” the statement said.
The FDA was quick...
To view the full article, register now.